In the field of hearing research, recent advances using the mouse as a model for human hearing loss have brought exciting insights into the molecular pathways that lead to normal hearing, and into the mechanisms that are disrupted once a mutation occurs in one of the critical genes. Inaccessible for most procedures other than high-resolution computed tomography (CT) scanning or invasive surgery, most studies on the ear in humans can only be performed postmortem. A major goal in hearing research is to gain a full understanding of how a sound is heard at the molecular level, so that diagnostic and eventually therapeutic interventions can be developed that can treat the diseased inner ear before permanent damage has occurred, such as hair cell loss. The mouse, with its advantages of short gestation time, ease of selective matings, and similarity of the genome and inner ear to humans, is truly a remarkable resource for attaining this goal and investigating the intrigues of the human ear.
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The Mouse in Biomedical and Inner Ear Research
The mouse has proven itself time and again as an exemplary model system for mammalian biology and human disease. This furry creature, though offensive to some, has provided insight about many human diseases and disorders, including cancer, heart disease, neurological disease, and most notably, hearing impairment. There is already an impressive collection of mouse mutants with hearing and/or vestibular dysfunction. In 1980, before there was discussion of the sequencing of the mouse genome (or human genome), there were but 50 mutant genes known to cause inner ear defects in mice, based on existing deaf mouse mutants (Deol, 1980) . Today, not only have many of these mutant genes been cloned, but there are more than 80 mutants generated by gene-targeted mutagenesis (knockouts) alone with an inner ear phenotype (Anagnostopoulos, 2002) (Table 1) .
Mice provide several advantages over other model organisms, particularly for the field of hearing research. First, the mouse is a mammal and hence its cochlea is remarkably similar to that of humans, despite other clearly observable differences between the two species. As in humans, the mechanosensory cells in mice are responsible for detecting sound in the cochlea and gravity and acceleration in the vestibular system. In the mouse organ of Corti, hair cells are arranged in one row of inner hair cells (IHC) and three rows of outer hair cells (OHC), with actin-rich stereocilia projecting on their apical surface. In the vestibular system, hair cells are arranged in patches in the saccule, utricle and semicircular canals. Defects in the vestibular system, often associated with deafness, are more severe in mice, leading to head bobbing or circling. For this reason, deaf mice have been easily recognizable; in fact, until a few years ago, the only mouse mutant involving the ear without vestibular dysfunction was the deafness (dn) mouse (Steel & Bock, 1980) . For experimental procedures, the mouse has long been recognized as a model of choice since its gestation time of 3 wk is relatively short. With proper care, mice thrive under controlled laboratory conditions. A major advantage offered by mice is the availability of inbred strains-genetically identical or isogenic mice-that provide a standard of comparison when comparing experiments between different laboratories. They also enable the study of a parameter without the complication of variable genetic background when repeating experiments. To become isogenic, inbred strains are generated after 20 generations of brother-sister matings (Silver, 1995; www.informatics.jax.org/silver/) . Common inbred lines are C57Bl/6 (for which a draft genome sequence is now available; see below), BALB/c, and 129/Sv. More specialized strains, such as congenic (mice with a chromosomal segment derived from one strain on the background of another inbred strain) and consomic/chromosome substitution strains (CSSs; entire chromosome placed on different genetic background) continue to play a major role in mouse genetics, particularly in identifying quantitative trait loci that underlie polygenic disease (Nadeau, Singer, Matin, & Lander, 2000) .
Excellent web resources are available that deal with mouse models for human disease and disorders, with some covering the inner ear in particular (Table 1) .
The History of the Mouse as a Model Organism
Human and mouse lineages are thought to have diverged between 90 and 140 million years ago (Bromham, Phillips, & Penny, 1999) . The first records of mouse mutants referred to coat color and other easily recognizable phenotypes, most notably dominant-spotting, albino, waltzing, and yellow mice. Referred to as "mouse fanciers," collectors in Japan, China and Europe in the 18th and 19th century bred these mice, generating what would later become laboratory mice. Once Mendel was rediscovered, pioneers in mouse genetics duplicated Mendel's pea experiments in mice, leading to the creation of inbred mice, many of which are used today (Silver, 1995) . The first report of genetic linkage in the mouse was that of the pink-eye dilution and albino loci, based on mouse crosses between mouse mutants with these phenotypes. More than half a decade later, the genes on chromosome 7 associated with these phenotypes were identified (Gardner et al., 1992; Kwon, Haq, Pomerantz, & Halaban, 1987) . In 1982, there were 45 loci on chromosome 7, representing mouse mutants, and serological and enzyme polymorphisms. Recombinant DNA technology provided the tools that led to where we stand today, with chromosome 7 represented by~2645 protein-encoding genes (Mouse Genome Resources, NCBI; www.ncbi.nlm.nih.gov/ genome/guide/mouse/index.html) and 122 Mb in sequence (Waterston et al., 2002) . In some cases, it took the completion of the draft sequence to identify genes not previously identified in one or the other genome. For example, otoferlin was discovered to be associated with human deafness in 1999 (Yasunaga et al., 1999) , but it was only with the sequencing of the mouse genome that the mouse orthologue was found (Waterston et al., 2002) .
Mouse genetics has a long history, much before the structure of chromosomes was even known. The early 1900s brought recognition of the mouse as a model for human disease, and interest in these animals shifted from the mouse fanciers to the laboratory. As early as 1928, spontaneous and radiation-induced mutations were discovered to have hearing and vestibular defects, for example, shaker 2 (sh2) (Dobrovolskaia-Zavasdkaia, 1928 ), but it was not until the last decade of the 20th century that the gene responsible for the phenotype was discovered .
The Mouse Genome
Comparative genomics has provided an incredibly useful tool for identifying human disease genes. Stretches of 1 to 50 centimorgans of chromosomes are conserved between humans and mice, with orthologous genes present along each chromosome. In fact, there are approximately 200 such shared homologous regions between human and mouse chromosomes, termed "syntenic" regions (Copeland, Jenkins, & O'Brien, 2002) . Existing mouse models for some of these genes have allowed predictions of candidate genes for human disease and disorders. One of the truly remarkable advances for using the mouse as a model for human disease is the ability to determine the chromosomal localization of a mouse gene and correlate it with the human chromosomal location and when available, mouse mutant. The field of hearing loss has demonstrated the value of comparative genomics over and over again. For example, the Pou4f3 mouse gene location and mouse knockout provided the key for discovering the gene for a human form of non-syndromic progressive hearing loss, DFNA15 (Vahava et al., 1998; Van Laer, Cryns, Smith, & Van Camp, 2003) . Identification of the mouse gene for spinner (sr), shaker 1 (sh1), and shaker 2 (sh2) led to the identification of the orthologous human genes and human deafness loci for DFNB6, USH1B/DFNB2/DFNA11, and DFNB3, respectively (see Table 2 ). The opposite holds true as well; in some cases, discovery of the human deafness genes has led to identification of the mouse genes, as was the case for DFNB7/B11 and DFNA36 for the genes for deafness (dn) and Beethoven (Bth), respectively (see Table 2 ).
Initial sequencing of the mouse genome has revealed a tremendous amount of valuable information for biomedical research. The draft sequence of the human genome, released in 2001 (Lander et al., 2001) , was followed by that of the mouse in late 2002 (Waterston et al., 2002) . The 
A Plethora of Mouse Mutants
There are three major forms of mouse mutants-spontaneous, radiation or chemical induced, and transgenics or knock-outs. For hearing and vestibular mutants, the first form numbers approximately 60 that have arisen spontaneously in mouse facilities throughout the world over many years. Many of these are derivatives of the mouse fanciers collections. Examples of these mutants are shaker 2 (sh2), shaker 1 (sh1), waltzer 1928 , 1929 , 1945 and 1966 , respectively (Deol & Green, 1966 Dobrovolskaia-Zavasdkaia, 1928; Gates, 1929; Snell, 1945) . All are now known to be models for human forms of syndromic and nonsyndromic deafness, and in several cases, the mouse deafness gene led to the discovery of the human deafness gene. For example, a myosin VI mutation causing deafness in the Snell's waltzer mouse led investigators to specifically search for human mutations in this gene. Human myosin VI mutations are now known to be associated with both dominant and recessive forms of hearing loss Melchionda et al., 2001) The second major form of mouse mutants are radiation or chemical induced, and in some cases were byproducts of large-scale mutagenesis experiments designed to study the effects of radiation on the germline (Russell, 1971) . Notable examples of radiation-induced mutations are alleles of piebald with mutations in Ednrb, a model for Waardenburg syndrome type IV (WS4; Hirschsprung disease) (Shin, Russell, & Tilghman, 1997) , the short ear Snell's waltzer (se sv ) allele of the deaf Snell's waltzer (Avraham et al., 1995) , and the first allele of shaker 2 (sh2) (Dobrovolskaia-Zavasdkaia, 1928) . Mouse spermatogenic cells are particularly susceptible to mutagenesis by chemicals such as N-ethyl-N-nitrosourea (ENU) and chlorambucil (CHL). Most recently, several large ENU-mutagenesis screens have been initiated (Justice, Noveroske, Weber, Zheng, & Bradley, 1999) , leading to a large number of mouse models for human diseases including hearing and balance mutants, including a model for otitis media in children (Hardisty et al., 2002; Kiernan et al., 2001; Tsai et al., 2001; Vreugde et al., 2002) .
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The third and most "modern" of the mouse mutants are transgenics and gene-targeted knock-outs. The first transgenic mouse made by microinjection of a foreign gene directly into the embryo was in 1980 (Gordon, Scangos, Plotkin, Barbosa, & Ruddle, 1980) . Since then, the advances in this area have been dramatic, with the ability today to conditionally knock-out a gene in a specific tissue (Kuhn, Schwenk, Aguet, & Rajewsky, 1995) , as was done to study the loss of connexin 26 specifically in the inner ear of mice (see below; Cohen-Salmon et al., 2002) . Standard transgenic mice typically contain 1 to 1000 copies of the microinjected foreign gene, with the gene usually up to 10 kb in length. This requires the gene to be injected to be small, or to inject the cDNA, in which case expression can often be compromised due to lack of introns. Bacterial artificial chromosomes (BACs) containing foreign genes of up to 300 kb in length (Shizuya et al., 1992) can now be injected to produce transgenic mice (Yang, Model, & Heintz, 1997) . BAC transgenesis was used to rescue the sh2 circling and deaf phenotype, leading to the discovery of the myosin XVa (Myo15a) gene for both the sh2 phenotype and a recessive form of nonsyndromic deafness, DFNB3 Wang et al., 1998) .
Transgenesis offers the advantage of allowing one to follow expression of a gene using a reporter gene, such as green fluorescent protein (GFP) or the LacZ/F␤-galactosidase gene. To identify the myosin VIIA promoter, the GFP reporter gene was subcloned under the control of several putative promoter regions of myosin VIIA and injected into mouse embryos to generate transgenic mice (Boeda, Weil, & Petit, 2001 ). The inner hair cells and outer hair cells of the apical turn were labeled green when exposed to fluorescence, corresponding to regulation of expression of myosin VIIa in these cells (Fig. 1) .
Gene-targeted mutagenesis, or knock-out technology, is an extension of transgenic technology, whereby a mutation is made in embryonic stem cells, and once cells carrying this deletion or insertion are selected, they are injected into blastocysts that are implanted into mice (Joyner, 2000) . Endogenous gene expression can be studied by substituting the gene with a reporter gene with gene-targeted technology and observing reporter gene expression in the heterozygous state. Expression of the Math1 gene was visualized by replacing the Math1 coding region with ␤-galactosidase, showing localization of this gene in the sensory epithelium of the cochlea and vestibule (among other places) (Bermingham et al., 1999) . A very thorough review of mouse knockouts with inner ear defects was recently published (Anagnostopoulos, 2002) .
Inner Ear Development and Hair Cell Organization
One of the mouse's greatest contributions to the inner ear research is the ability to study the expression of a gene or protein during embryonic development and hair cell differentiation, as well as morphology. This can be done in one or more ways. The first is by detection of messenger RNA (mRNA) derived from the inner ear by extracting inner ear or cochlear RNA and performing reverse-transcription (RT)-polymerase chain reaction (PCR), using primers specific for one's gene of interest (Fig. 2) . Real-time PCR provides a quantitative (or semi-quantitative) method for evaluating the level of mRNA in specific tissues (Walker, 2002) . Levels of Myo15a, Tmc1, Tmc2, and Pres were shown to be very low between embryonic day (E) 14 and postnatal day (P) 0 and peak at P10 . Myo15a and Tmc1 mutations are associated with deafness in sh2, and dn and Bth mice, respectively, as well as in humans (Table 1) . A second method is in situ hybridization, where a radioactive or non-radioactive (colorimetric) label is incorporated into the DNA derived from a portion of the gene of interest, and hybridized to a whole embryo or cochlea or tissue section (Fig. 3) . A third method is immunofluorescence, where an antibody is labeled to a dissected cochlea or tissue section (Fig. 4) . A study of the localization of myosin VIIa, harmonin b, and cadherin 23 in differentiating hair cells, along with cell culture-transfection studies, demonstrated that the three proteins work together to form the 
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EAR & HEARING / AUGUST 2003 hair cell bundle (Boeda et al., 2002) . Each is associated with syndromic and/or nonsyndromic hearing loss; mutations in myosin VIIA are responsible for Usher syndrome type IB (USH1B) and DFNB2/DFNA11, mutations in harmonin for USH1C, and mutations in cadherin 23 for USH1D (Friedman et al., 2003, in this issue) . Visualization of the morphology of hair cells can also provide valuable information about hair cell structure and loss ). To visualize morphology in inner ears of mouse mutants, scanning electron microscopy (SEM) reveals defects in differentiation and formation of hair bundles and/or cellular architecture, and/or postnatal degeneration. A study of Bth mice, for example, revealed progressive hair cell degeneration, suggesting this mouse to be an appropriate model for this type of hearing loss in humans; the discovery of a mutation in Tmc1, the mouse orthologue of the DFNA36/TMC1 gene, confirmed this hypothesis (Fig. 5A, B) . Abnormally thin stereocilia are shown by scanning electron microscopy (SEM) in Tasmanian devil (tde) mutants (see below; Fig. 5C, D) .
What We Have Learned from the Mouse
Mouse mutants not only provide us with identification of genes, but even more important, they supply us with a detailed account of protein interaction and insight into developmental and functional pathways.
Norrie disease, an X-linked recessive syndromic form of deafness, is also characterized by blindness and mental retardation. In the inner ear, NDP, the gene responsible for Norrie disease, is expressed in spiral ganglion and stria vascularis. The null mutation of NDP leads to stria vascularis pathology and a reduction in vessel size, suggesting that the role of norrin is to link the cochlea with its vasculature (Rehm et al., 2002) .
Connexin 26 mutations lead to the most prevalent form of non-syndromic hearing loss, but details regarding the pathology of connexin 26 malfunction in hair cells has remained elusive until recently. The connexin 26 knock-out mice die during embryogenesis due to differences in placental layers between humans and mice (Gabriel et al., 1998) . Connexin 26 was inactivated using the Cre-lox P recombination system (Kuhn et al., 1995) in order to target the epithelial gap junction network that contains supporting cells and flanking epithelial cells. Removal of connexin 26 in the epithelial network where this protein is expressed led to cell death of supporting cells of the inner hair cells (Cohen-Salmon et al., 2002) . Therefore the connexin 26 epithelial gap junction network in the cochlea is essential for hearing. Prevention of apoptosis in connexin 26 deafness may form the basis for a therapeutic approach. 
More Genes Required
Considering that there are more than 90 deafness loci mapped in humans and only 30 of these genes have been cloned (updated regularly at the Hereditary Hearing Loss Homepage; http://dnalab-www.uia.ac. be/dnalab/hhh/index.html), there is clearly a need for the discovery of new genes in the auditory and vestibular pathway. Most compelling, a thorough morphological characterization of the mouse phenotype can be done before a gene is cloned, so that once the gene is found, essential information about the gene's product function is already known. An ever-growing number of reports describe the morphological phenotype of the inner ears of mouse mutants, but the responsible gene remains elusive. Nevertheless, the descriptions have provided important insights regarding hair cell development and stereociliar formation. The Tasmanian devil (tde) mutation was caused by insertional mutagenesis of a transgene and disruption of an as-yet unidentified gene. Homozygous mice for the insertion exhibit circling and hearing loss . Hair cell stereocilia are much thinner than normal and the hair cells become disorganized and eventually die (Fig. 5C, D) . Therefore the tde gene may disrupt proper formation of actin filaments, either directly or through interaction with other actin-associated proteins. The hair cells of whirler (wi), a recessive mouse mutant whose phenotype is deaf and circling, have been analyzed extensively. Stereocilia are half the size of their normal counterparts, which appears to manifest itself by a reduction in their elongation after P1 (Holme, Kiernan, Brown, & Steel, 2002) . Since Myo15a is expressed in stereocilia during elongation (Anderson et al., 2000) , the wi and sh2 gene products may interact.
In addition, several mouse knock-outs have been made that demonstrate that the targeted gene has a vital role in the inner ear, although mutations in these genes have not been identified in humans. Nevertheless, these mice identify key roles for these genes in the development of inner ear structures. A null mutation in Nkx5-1, a homeobox gene expressed in vestibular structures throughout development, leads to circling and hyperactive activity (Hadrys, Braun, RinkwitzBrandt, Arnold, & Bober, 1998) . As there is a severe loss or reduction in the formation of the semicircular canals in these mice, the circling appears due to defects in the sensory organ and not to abnormalities in the central nervous system (although these cannot be completely ruled out). Gene-targeted mutagenesis of the Barhl1 homeobox gene leads to severe to profound hearing loss with no associated vestibular dysfunction (Li, Price, Cahill, Ryugo, Shen, & Xiang, 2002) . Progressive cochlear hair cell degeneration is observed, leading to the conclusion that Barhl1 is essential for long-term maintenance of cochlear hair cells. Neurotrophins have been implicated in inner ear development and the knock-outs of BDNF and NT-3 provide compelling evidence from this perspective (Ernfors, Van De Water, Loring, & Jaenisch, 1995) . Sensory organs from the cochlea and vestibular inner ear are innervated by afferents from spiral ganglion neurons and vestibular ganglion neurons, respectively. Trophic factors, including the neurotrophins, support the survival of these neurons (reviewed in Fritzsch et al., 2002) . A null mutation in BDNF leads to loss of vestibular ganglion neurons and afferents, whereas a null mutation in NT-3 leads to loss of mostly spiral ganglion neurons and afferents. Gene-targeted mutagenesis of the Slc12a7 gene encoding the Kϩ/ClϪ co-transporter Kcc4 leads to deafness and renal tubular acidosis (Boettger, Hubner, Maier, Rust, Beck, & Jentsch, 2002) . This discovery has led to the hypothesis that Kcc4 is crucial for Kϩ recycling by transporting Kϩ from OHC to supporting Deiters' cells. The BETA2/ NeuroD1 gene, a basic helix-loop-helix transcription factor up-regulates insulin gene expression and is essential for the development of the brain and pancreas. Surprisingly, a null mutation in the mice leads to circling and deafness and further investigation revealed that this phenotype is caused by a decline of sensory neurons in the cochlear-vestibular ganglion (CVG), as well as abnormalities in differentiation and patterning of the sensory epithelium (Liu et al., 2000) . Yet another null mutation in a transcription factor, FoxI1, leads to an absence of cochlear and vestibular structures, which are replaced with a cavity (Hulander, Wurst, Carlsson, & Enerback, 1998) . Most interesting, each of the above knock-outs demonstrates a crucial role of a different pathway and/or cell type in the inner ear, demonstrating how together, these mice provide a comprehensive picture of inner ear development and function.
CONCLUSION
Hundreds of mouse models are now known to have hearing and/or balance defects, and each one provides a piece of the puzzle in our understanding of inner ear biology. Some are directly relevant to human deafness and others provide key elements in the development and function of sensory structures of the ear. Regardless, it is clear that using this mammal to study the human inner ear has and will continue to make a tremendous impact on the field.
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